Scarica l'app Stockscreener
67.45
0.78%
0.52
Dopo l'orario di chiusura:
66.49
-0.96
-1.42%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRUS Giù?
Forum
Previsione
Precedente Chiudi:
$66.93
Aprire:
$67.19
Volume 24 ore:
557.24K
Relative Volume:
0.51
Capitalizzazione di mercato:
$4.67B
Reddito:
$35.93M
Utile/perdita netta:
$-244.56M
Rapporto P/E:
-17.08
EPS:
-3.95
Flusso di cassa netto:
$-157.31M
1 W Prestazione:
+2.32%
1M Prestazione:
+25.33%
6M Prestazione:
+61.91%
1 anno Prestazione:
+34.71%
Intervallo 1D:
$66.02
$67.47
Intervallo di 1 settimana:
$64.48
$67.59
Portata 52W:
$33.19
$67.59
Merus N V Stock (MRUS) Company Profile
Nome
Merus N V
Settore
Industria
Telefono
31 030 253 8800
Indirizzo
YALELAAN 62, 3584 CM UTRECHT
Confronta MRUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
67.45 | 4.88B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Piper Sandler | Overweight |
| 2025-02-07 | Iniziato | Wells Fargo | Overweight |
| 2024-11-21 | Iniziato | Goldman | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-03-28 | Iniziato | Truist | Buy |
| 2024-03-04 | Reiterato | Needham | Buy |
| 2023-11-02 | Iniziato | Canaccord Genuity | Buy |
| 2023-08-21 | Iniziato | TD Cowen | Outperform |
| 2022-08-02 | Iniziato | Stifel | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Needham | Buy |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-06-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-08 | Iniziato | William Blair | Outperform |
| 2021-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | Ripresa | Guggenheim | Buy |
| 2019-06-28 | Iniziato | ROTH Capital | Buy |
| 2019-04-12 | Ripresa | Guggenheim | Buy |
| 2019-04-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2018-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-03-21 | Downgrade | Citigroup | Buy → Neutral |
| 2016-12-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-11-07 | Downgrade | Citigroup | Buy → Neutral |
| 2016-06-13 | Iniziato | Citigroup | Buy |
| 2016-06-13 | Iniziato | Guggenheim | Buy |
| 2016-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Merus N V Borsa (MRUS) Ultime notizie
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - Stock Titan
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Merus Awards Massive $15.7M Stock Options Package to Key New Hires in Oncology Push - Stock Titan
What is Merus N.V. company’s growth strategyInvest confidently with professional guidance - Jammu Links News
Does Merus N.V. stock perform well during market downturnsStrong return on assets - Jammu Links News
What is the risk reward ratio of investing in Merus N.V. stockUnlock superior stock analysis tools - Jammu Links News
How volatile is Merus N.V. stock compared to the marketBuild wealth faster with expert stock picks - Jammu Links News
What institutional investors are buying Merus N.V. stockGet daily updates on promising stocks - Jammu Links News
Should I hold or sell Merus N.V. stock in 2025Get insider insights into market trends - Jammu Links News
What makes Merus N.V. stock price move sharplyConsistent high-yield stocks - Jammu Links News
Is it the right time to buy Merus N.V. stockHigh-yield trading alerts - Jammu Links News
Bank of America Securities Maintained a Buy Rating on Merus N.V (MRUS) - MSN
10 Best All-Time High Stocks to Buy According to Analysts - Insider Monkey
Merus N.V.’s Phase 3 Study on Petosemtamab: A Potential Game-Changer for HNSCC Treatment - TipRanks
Merus N.V. Flashes Buy Signal on Multi Timeframe ChartWeekly Setup With 3x Return Potential Published - metal.it
Options Data Show Bullish Bias in Merus N.V.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
RSI Crosses Above 30 for Merus N.V. — Reversal in SightShort Term Setup With Predictive Chart Confirmed - metal.it
When is Merus N.V. stock expected to show significant growthStock Market Opportunities For Every Investor - Jammu Links News
Why is Merus N.V. stock attracting strong analyst attentionGrow your portfolio with growth-oriented stocks - Jammu Links News
What are Merus N.V. company’s key revenue driversRapid wealth creation - jammulinksnews.com
Merus NV stock reaches all-time high at 66.44 USD By Investing.com - Investing.com South Africa
Merus NV stock reaches all-time high at 66.44 USD - Investing.com
Why Merus N.V. stock is on top investor watchlistsHigh-impact stock picks - jammulinksnews.com
How high can Merus N.V. stock price go in 2025Fastest return on investment - Jammu Links News
Merus N.V. Stock Analysis and ForecastGame-changing returns - Jammu Links News
What analysts say about Merus N.V. stockDynamic growth stocks - jammulinksnews.com
What drives Merus N.V. stock pricePhenomenal trading returns - Autocar Professional
Is Merus N.V. a good long term investmentRapidly expanding wealth - Autocar Professional
Merus N V Azioni (MRUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):